Posts in category Analyst News


Finisar Corporation (FNSR) Collaboration with Apple Inc. (AAPL) on VCSEL Arrays Is a ‘Strong Positive’: Analyst

William Blair’s Dmitry Netis highlights key insights after meeting with FNSR CEO Kurt Adzema yesterday at the analyst’s Silicon Valley investor bus tour.

Read more

John Freeman Edges Down Price Target on Oasis Petroleum Inc. (OAS) But Still Angles for Substantial Upside

Even with slightly lower expectations, Raymond James’ John Freeman spotlights 66% upside potential for OAS shares.

Read more

Omeros Corporation (OMER) Wins Pediatrics Approval, but for This Bull the Excitement Is All About OMS721 Asset

Maxim’s Jason Kolbert is keeping his focus peeled to the Omeros pipeline, even though he welcomes the FDA victory for Omidria.

Read more

Brian Peterson Spotlights Greater Appreciation for Shopify Inc (US) (SHOP) Long-Term Growth Prospects After Management Meetings

The total addressable market opportunity for SHOP shines brightly ahead as Raymond James’ Brian Peterson makes a bullish case for the Canadian e-commerce platform.

Read more

Christopher Rolland Chimes in Cautious on Advanced Micro Devices, Inc. (AMD) and NVIDIA Corporation (NVDA); Here’s Why

How long will bull run last for GPU makers?

Read more

Global Blood Therapeutics Inc (GBT): Despite Reports of Two Patient Deaths, This Top Analyst Remains Bullish

Why patient deaths don’t necessarily scuttle Global Blood’s chances for voxelotor’s clinical success.

Read more

Jason McCarthy’s Take on Gilead Sciences, Inc. (GILD) Following ASH Data

ASH data offers insight into Gilead Sciences’ lymphoma drug Yescarta; Maxim’s Jason McCarth weighs in.

Read more

Bull Trims Down Price Target on LendingClub Corp (LC) Following Investor Day

Even with lower expectations., Maxim’s Michael Diana nonetheless highlights 104% in upside potential for LC shares.

Read more

Should You Bet on Volatile Bitcoin Price? Tech Guru Gene Munster Says “It Sure Seems Like Crypto Is in a Bubble”

Loup Ventures’ Gene Munster likens the Bitcoin revolution to that of the dot-com bubble collapse- but technological transformation of the way humans live in the world today.

Read more

Analyst Looks Beyond Sophiris Bio Inc (SPHS) Completed Phase 2b Enrollment to Large Opportunity Awaiting in Prostate Cancer Market

Maxim’s Jason Kolbert is betting on SPHS to “unlock” share value with prostate cancer asset topsalysin.

Read more